FDA approves Ascendis Pharma's hormone disorder therapy-March 2024-www.financetom.com

FDA approves Ascendis Pharma's hormone disorder therapy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

FDA approves Ascendis Pharma's hormone disorder therapy

Aug 12, 2024 4:24 AM

Aug 12 (Reuters) - The U.S. Food & Drug Administration

has approved Ascendis Pharma's ( ASND ) therapy to treat adult

patients with a hormone disorder, bringing an end to its

years-long efforts to introduce the treatment to the market, the

company said on Monday.

(Reporting by Sriparna Roy and Sneha S K in Bengaluru; Editing

by Shinjini Ganguli)

Previous page： Intrepid Potash Insider Sold Shares Worth $2,006,970, According to a Recent SEC Filing Next page： Sector Update: Consumer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Intrepid Potash Insider Sold Shares Worth $2,006,970, According to a Recent SEC Filing

Mar 18, 2025

01:46 PM EDT, 03/18/2025 (MT Newswires) -- Robert P Jornayvaz III, 10% Owner, on March 14, 2025, sold 73,517 shares in Intrepid Potash ( IPI ) for $2,006,970. Following the Form 4 filing with the SEC, Jornayvaz has control over a total of 1,195,693 common shares of the company, with 56,987 shares held directly and 1,138,706 controlled indirectly. SEC Filing:...

Sector Update: Consumer

Mar 18, 2025

01:44 PM EDT, 03/18/2025 (MT Newswires) -- Consumer stocks were lower Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) down 0.6% and the Consumer Discretionary Select Sector SPDR Fund (XLY) dropping 1.5%. Redbook US same-store sales rose by 5.2% from a year earlier in the week ended March 15, slower than the 5.7% year-over-year increase in the...

Walmart Builds Generative AI Tool for Merchants

Mar 18, 2025

01:45 PM EDT, 03/18/2025 (MT Newswires) -- Walmart ( WMT ) has developed a generative artificial intelligence-powered tool to improve the productivity of its merchants. Dubbed Wally, the tool automates processes such as data entry and analysis, root cause identification and advanced calculations, the company said Tuesday in a statement. Walmart ( WMT ) built the tool using its proprietary...

Outset Medical to Implement 1-for-15 Reverse Stock Split

Mar 18, 2025

01:39 PM EDT, 03/18/2025 (MT Newswires) -- Outset Medical ( OM ) said Tuesday it is implementing a one-for-15 reverse stock split of its common stock, with its shares to begin trading on a split-adjusted basis on March 20. The reverse stock split will reduce the number of shares to about 17 million from around 265 million, the company said....